Ptpn2 limits plasma cell fate and antiviral immunity by integrating B cell receptor and IFN-γ signals in B cells
Science Advances · 21.08.2026 · 12 (34)
DOI: 10.1126/sciadv.aec0162 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 21.08.2026. Verfasst von Ana Maria Hincapie und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, McGill University, Montreal, QC, Canada. Hauptthemen laut MEDLINE: Interferon-gamma, Signal Transduction, Protein Tyrosine Phosphatase, Non-Receptor Type 2, B-Lymphocytes. Die Arbeit nennt 105 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Canadian institute of Health Research, Canadian Institute of Health Research Project Grant, Aclon Foundation.
Abstract (Originalsprache)
Antigen-specific humoral responses are critical for long-term protection against infectious diseases, yet the mechanisms that regulate B cell differentiation and antibody production remain incompletely defined. Here, we identify the Protein Tyrosine Phosphatase Nonreceptor Type 2 (Ptpn2) as a B cell–intrinsic regulator of plasma cell fate and isotype switching. Using a B cell–specific Ptpn2 knockout mouse model, we show that Ptpn2 restrains both B cell receptor and interferon-γ (IFN-γ) signaling by directly dephosphorylating Lyn, STAT1, and STAT3. Loss of Ptpn2 leads to hyperactivation of these two signaling pathways, resulting in transcriptional reprogramming that promotes plasma cell differentiation and increased IFN-γ–driven antibody production. Functionally, Ptpn2-deficient mice generated enhanced primary antiviral antibody responses following influenza infection and elevated virus-specific and neutralizing titers upon recall without compromising affinity. These findings identify Ptpn2 as a key intracellular checkpoint that integrates antigenic and inflammatory cues to regulate humoral immunity, with potential implications for enhancing vaccine-induced protective immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, McGill University, Montreal, QC, Canada.
- Goodman Cancer Institute, McGill University, Montreal, QC, Canada.
- Department of Physiology, McGill University, Montreal, QC, Canada.
- McGill University Research Centre on Complex Traits, Montreal, QC, Canada.
- Department of Microbiology and Immunology, Montreal, QC, Canada.
- Department of Human Genetics, McGill University, Montreal, QC, Canada.
ORCID-Profile: Ana Maria Hincapie, Alexandre Poirier, Isabelle Aubry, Aanya Bhagrath, Chenyue Wu, Stephanie Bussieres-Marmen, Belma M Abidin, Javier M Di Noia, Judith N Mandl, Silvia M Vidal, Jorg H Fritz, Michel L Tremblay
Förderung
- Canadian institute of Health Research
- Canadian Institute of Health Research Project Grant
- Aclon Foundation
- Richard and Edith Strauss Canada Foundation
- Canderel Studentship
- Cole Foundation Studentship
- Hugh E. Burke Studentship
Zitieren
APA
Hincapie, A. M., Poirier, A., Aubry, I., Aumont, P., Bhagrath, A., Uetani, N., Colalillo, B., Wu, C., Charbonneau, B., Bussieres-Marmen, S., Abidin, B. M., Di Noia, J. M., Mandl, J. N., Vidal, S. M., Fritz, J. H., & Tremblay, M. L. (2026). Ptpn2 limits plasma cell fate and antiviral immunity by integrating B cell receptor and IFN-γ signals in B cells. Science Advances, 12(34). https://doi.org/10.1126/sciadv.aec0162
Vancouver
Hincapie AM, Poirier A, Aubry I, Aumont P, Bhagrath A, Uetani N, et al. Ptpn2 limits plasma cell fate and antiviral immunity by integrating B cell receptor and IFN-γ signals in B cells. Science Advances. 2026;12(34). doi:10.1126/sciadv.aec0162
BibTeX
@article{Hincapie2026,
author = {Hincapie, Ana Maria and Poirier, Alexandre and Aubry, Isabelle and Aumont, Philippe and Bhagrath, Aanya and Uetani, Noriko and Colalillo, Bianca and Wu, Chenyue and Charbonneau, Benoit and Bussieres-Marmen, Stephanie and Abidin, Belma M and Di Noia, Javier M and Mandl, Judith N and Vidal, Silvia M and Fritz, Jorg H and Tremblay, Michel L},
title = {Ptpn2 limits plasma cell fate and antiviral immunity by integrating B cell receptor and IFN-γ signals in B cells},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {34},
doi = {10.1126/sciadv.aec0162}
}
EUVIMED